학술논문
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Document Type
Article
Author
Murray Brunt, A.; Haviland, J.S.; Sydenham, M.A.; Hopwood, P.; Stones, L.; Bliss, J.M.; Wheatley, D.A.; Alhasso, A.; Bloomfield, D.J.; Chan, C.; Churn, M.; Cleator, S.; Coles, C.E.; Goodman, A.; Harnett, A.; Kirby, A.M.; Somaiah, N.; Yarnold, J.R.; Kirwan, C.C.; Morris, C.; Nabi, Z.; Sawyer, E.; Syndikus, I.; Armstrong, A.; Bliss, J.; Bloomfield, D.; Bowen, J.; Brunt, M.; Chantler, H.; Donovan, E.; Goodman, A.; Griffin, S.; Haviland, J.; Hopwood, P.; Kirby, A.; Kirk, J.; MacLennan, M.; Sculphur, M.; Sinclair, J.; Sydenham, M.; Tremlett, J.; Venables, K.; Wheatley, D.; Yarnold, J.
Source
In: The Lancet . (The Lancet, 23 - 29 May 2020, 395(10237):1613-1626)
Subject
Language
English
ISSN
1474547X
01406736
01406736